Davis Andrew's most recent trade in Howard Hughes Holdings Inc was a trade of 396 Common stock, $0.01 par value per share done at an average price of $80.0 . Disclosure was reported to the exchange on Feb. 5, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Howard Hughes Holdings Inc | Andrew D. Davis | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 80.04 per share. | 05 Feb 2026 | 396 | 33,166 (0%) | 0% | 80.0 | 31,696 | Common stock, $0.01 par value per share |
| Howard Hughes Holdings Inc | Andrew D. Davis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 9,994 | 33,562 (0%) | 0% | 0 | Common stock, $0.01 par value per share | |
| Howard Hughes Holdings Inc | Andrew D. Davis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 3,011 | 22,657 (0%) | 0% | 0 | Common stock, $0.01 par value per share | |
| Howard Hughes Holdings Inc | Andrew D. Davis | See Remarks | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2026 | 2,498 | 23,568 (0%) | 0% | 0 | Common stock, $0.01 par value per share | |
| Howard Hughes Holdings Inc | Andrew D. Davis | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.77 per share. | 03 Feb 2026 | 1,587 | 21,070 (0%) | 0% | 79.8 | 126,595 | Common stock, $0.01 par value per share |
| Howard Hughes Holdings Inc | Andrew D. Davis | See Remarks | Payment of exercise price or tax liability using portion of securities received from the company at price $ 79.77 per share. | 31 Dec 2025 | 457 | 19,646 (0%) | 0% | 79.8 | 36,455 | Common stock, $0.01 par value per share |
| Old Dominion Freight Line | Andrew S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 May 2025 | 1,029 | 2,776 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 4.08 per share. | 18 Nov 2024 | 5,360 | 284,685 (0%) | 0% | 4.1 | 21,869 | Class A Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2024 | 290,077 | 0 (0%) | 0% | - | Common Stock | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2024 | 62,958 | 0 | - | - | Employee Stock Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Sep 2024 | 42,218 | 42,218 (0%) | 0% | 0 | Common Stock | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2024 | 42,218 | 0 (0%) | 0% | - | Common Stock | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2024 | 33,220 | 0 | - | - | Employee Stock Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2024 | 22,033 | 0 | - | - | Employee Stock Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Sep 2024 | 1,853 | 0 | - | - | Employee Stock Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 6.45 per share. | 20 May 2024 | 22,725 | 288,031 (0%) | 0% | 6.4 | 146,576 | Class A Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 7.05 per share. | 20 May 2024 | 2,000 | 289,773 (0%) | 0% | 7.1 | 14,100 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 27.00 per share. | 20 May 2024 | 66 | 289,707 (0%) | 0% | 27 | 1,782 | Common Stock |
| Old Dominion Freight Line | Andrew S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 May 2024 | 795 | 1,747 (0%) | 0% | 0 | Common Stock | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 37,120 | 310,756 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Mar 2024 | 37,120 | 0 | - | - | Performance-based Restricted Stock Unit | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Mar 2024 | 62,201 | 293,254 (0%) | 0% | 0 | Common Stock | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 17.17 per share. | 01 Mar 2024 | 5,481 | 287,773 (0%) | 0% | 17.2 | 94,103 | Common Stock |
| Ironwood Pharma Inc (Class A) | Davis Andrew | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 65,312 | 273,636 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Davis Andrew | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Feb 2024 | 32,656 | 32,656 | - | - | Performance-based Restricted Stock Unit | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 15.24 per share. | 12 Feb 2024 | 9,846 | 208,324 (0%) | 0% | 15.2 | 150,053 | Class A Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 30.78 per share. | 06 Jul 2023 | 69 | 115,614 (0%) | 0% | 30.8 | 2,124 | Common Stock |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 10.12 per share. | 22 May 2023 | 6,305 | 219,327 (0%) | 0% | 10.1 | 63,807 | Class A Common Stock |
| Old Dominion Freight Line | Andrew S. Davis | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2023 | 476 | 476 (0%) | 0% | 0 | Common Stock | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 3,213 | 44,238 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.51 per share. | 01 May 2023 | 3,213 | 115,683 (0%) | 0% | 44.5 | 143,019 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 01 May 2023 | 3,213 | 122,436 (0%) | 0% | 4.7 | 15,197 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 2,584 | 18,720 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.51 per share. | 01 May 2023 | 2,584 | 118,896 (0%) | 0% | 44.5 | 115,020 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 01 May 2023 | 2,584 | 119,223 (0%) | 0% | 4.7 | 12,222 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 01 May 2023 | 482 | 116,165 (0%) | 0% | 6.1 | 2,945 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 482 | 1,853 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.51 per share. | 01 May 2023 | 482 | 121,954 (0%) | 0% | 44.5 | 21,455 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 May 2023 | 474 | 33,220 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.51 per share. | 01 May 2023 | 474 | 121,480 (0%) | 0% | 44.5 | 21,099 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 01 May 2023 | 474 | 116,639 (0%) | 0% | 20 | 9,480 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.42 per share. | 03 Apr 2023 | 4,966 | 115,683 (0%) | 0% | 39.4 | 195,760 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 03 Apr 2023 | 4,966 | 122,436 (0%) | 0% | 4.7 | 23,489 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 4,966 | 21,304 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 03 Apr 2023 | 1,475 | 117,470 (0%) | 0% | 4.7 | 6,977 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.42 per share. | 03 Apr 2023 | 1,475 | 120,649 (0%) | 0% | 39.4 | 58,145 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,475 | 47,451 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 6.11 per share. | 03 Apr 2023 | 312 | 115,995 (0%) | 0% | 6.1 | 1,906 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 39.42 per share. | 03 Apr 2023 | 312 | 122,124 (0%) | 0% | 39.4 | 12,299 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 312 | 2,335 | - | - | Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 74,236 | 225,632 (0%) | 0% | 0 | Class A Common Stock | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2023 | 37,118 | 37,118 | - | - | Performance-based Restricted Stock Units | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Mar 2023 | 21,346 | 119,551 (0%) | 0% | 0 | Common Stock | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 47.74 per share. | 02 Mar 2023 | 3,868 | 115,683 (0%) | 0% | 47.7 | 184,653 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 5,939 | 48,926 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 48.02 per share. | 01 Mar 2023 | 5,939 | 98,205 (0%) | 0% | 48.0 | 285,184 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 01 Mar 2023 | 5,939 | 104,144 (0%) | 0% | 4.7 | 28,091 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2023 | 814 | 26,270 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 48.02 per share. | 01 Mar 2023 | 814 | 98,205 (0%) | 0% | 48.0 | 39,087 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 01 Mar 2023 | 814 | 99,019 (0%) | 0% | 4.7 | 3,850 | Common Stock |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.31 per share. | 27 Feb 2023 | 1,822 | 151,396 (0%) | 0% | 11.3 | 20,607 | Class A Common Stock |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.41 per share. | 27 Feb 2023 | 1,751 | 153,218 (0%) | 0% | 11.4 | 19,979 | Class A Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 54.05 per share. | 01 Feb 2023 | 6,753 | 98,205 (0%) | 0% | 54.1 | 365,000 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 01 Feb 2023 | 6,753 | 104,958 (0%) | 0% | 4.7 | 31,942 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 6,753 | 54,865 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 03 Jan 2023 | 5,175 | 103,380 (0%) | 0% | 1.6 | 8,280 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 52.87 per share. | 03 Jan 2023 | 5,175 | 98,205 (0%) | 0% | 52.9 | 273,602 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 5,175 | 22,033 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 03 Jan 2023 | 1,578 | 99,783 (0%) | 0% | 4.7 | 7,464 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 52.87 per share. | 03 Jan 2023 | 1,578 | 98,205 (0%) | 0% | 52.9 | 83,429 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Jan 2023 | 1,578 | 61,618 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 53.00 per share. | 01 Dec 2022 | 4,267 | 98,205 (0%) | 0% | 53 | 226,151 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.60 per share. | 01 Dec 2022 | 4,267 | 102,472 (0%) | 0% | 1.6 | 6,827 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 4,267 | 27,208 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 53.00 per share. | 01 Dec 2022 | 2,486 | 98,205 (0%) | 0% | 53 | 131,758 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 01 Dec 2022 | 2,486 | 100,691 (0%) | 0% | 1.5 | 3,630 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Dec 2022 | 2,486 | 0 | - | - | Option (right to buy) | |
| Ironwood Pharma Inc (Class A) | Andrew Davis | SVP, Chief Business Officer | Sale of securities on an exchange or to another person at price $ 11.56 per share. | 21 Nov 2022 | 3,335 | 154,213 (0%) | 0% | 11.6 | 38,553 | Class A Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 01 Nov 2022 | 6,753 | 104,958 (0%) | 0% | 1.5 | 9,859 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2022 | 6,753 | 2,486 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.17 per share. | 01 Nov 2022 | 6,753 | 98,205 (0%) | 0% | 44.2 | 298,280 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 44.76 per share. | 03 Oct 2022 | 6,753 | 98,205 (0%) | 0% | 44.8 | 302,264 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 03 Oct 2022 | 6,753 | 104,958 (0%) | 0% | 1.5 | 9,859 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Oct 2022 | 6,753 | 9,239 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 1.46 per share. | 01 Sep 2022 | 6,753 | 104,958 (0%) | 0% | 1.5 | 9,859 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Sep 2022 | 6,753 | 15,992 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 38.93 per share. | 01 Sep 2022 | 6,753 | 98,205 (0%) | 0% | 38.9 | 262,894 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 47.35 per share. | 03 Aug 2022 | 6,056 | 98,205 (0%) | 0% | 47.4 | 286,776 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Grant, award, or other acquisition of securities at price $ 24.51 per share. | 20 May 2022 | 550 | 104,261 (0%) | 0% | 24.5 | 13,481 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 37.80 per share. | 20 May 2022 | 69 | 103,711 (0%) | 0% | 37.8 | 2,608 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 3,343 | 33,694 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.96 per share. | 01 Nov 2021 | 3,343 | 70,255 (0%) | 0% | 61.0 | 203,789 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 20.00 per share. | 01 Nov 2021 | 3,343 | 73,598 (0%) | 0% | 20 | 66,860 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 988 | 31,187 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.96 per share. | 01 Nov 2021 | 988 | 70,255 (0%) | 0% | 61.0 | 60,228 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 30.93 per share. | 01 Nov 2021 | 988 | 71,243 (0%) | 0% | 30.9 | 30,559 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 321 | 27,084 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.96 per share. | 01 Nov 2021 | 321 | 70,255 (0%) | 0% | 61.0 | 19,567 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.73 per share. | 01 Nov 2021 | 321 | 70,576 (0%) | 0% | 4.7 | 1,518 | Common Stock |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Nov 2021 | 121 | 2,647 | - | - | Option (right to buy) | |
| Silk Road Medical Inc | Andrew S. Davis | Chief Commercial Officer | Sale of securities on an exchange or to another person at price $ 60.96 per share. | 01 Nov 2021 | 121 | 70,255 (0%) | 0% | 61.0 | 7,376 | Common Stock |